justbacked

Biotechnology, Clinical Trials, Health Care

NewLimit

NewLimit is a biotech company developing epigenetic therapies to extend human healthspan by reprogramming aging cells.

Series C · $435M · 127d agonewlimit.com

Hiring velocity

Open roles
12
Added, 30 days
+2
Added, 7 days
+0
Closed, 30 days
6
Raised
127 days ago
Led by
Draper Associates, Founders Fund, Khosla Ventures, Thrive Capital, Kleiner Perkins
Team size
11-50
HQ
South San Francisco, California, United States
Newest role
11d ago
Tracked since
Aug 21, 2026

Where they're hiring

Science7
Operations3
Engineering1

Open roles at NewLimit

$435M · 127d ago

NewLimit · Series C

Scientist, Metabolism

South San Francisco

$130K–$165K

Posted 11 days ago· Sep 25

ScienceLed by Draper Associates, Founders Fund
$435M · 127d ago

NewLimit · Series C

Executive Assistant

South San Francisco

Posted 98 days ago· Jul 1

Led by Draper Associates, Founders Fund
$435M · 127d ago

NewLimit · Series C

Scientist/Senior Scientist

South San Francisco, CA

$130K–$180K

Posted 384 days ago· Sep 17

ScienceLed by Draper Associates, Founders Fund

Source: newlimit.com, checked daily.